Dr. Tal Shahar
Director of the Oncology Neurosurgery Unit
- Expertise: Neurosurgery
Professional Experience
- 2002 /06 Training, Department of Neurosurgery, University of San Diego, California, USA
- 2004 Internship, Sourasky Medical Center Tel Aviv
- 2005-2008 Residency in neurosurgery, Sourasky Medical Center Tel Aviv
- 11/2007-01/2008 Training, Department of Neurology New South Wales University St. Vincent's Hospital, Sydney, Australia
- 02/2008-05/2008 Training, Department of Radiology New South Wales University, St.Vincent's Hospital, Sydney, Australia
- 2009-2010 Chief Resident, Department of Neurosurgery, Sourasky Medical Center Tel Aviv
- 08/2010 Training, Department of Neurosurgery St George's Hospital London, England
- 2011-2013 Subspecialty in Oncological Neurosurgery, Department of Neurosurgery, MD Anderson Cancer Center The University of Texas, Houston, Texas, USA.
- 2016-2014 Senior Neurosurgeon, Neurosurgical Unit, Sourasky Medical Center Tel Aviv
Training
- 08/2001 Doctor of Medicine (Summa Cum Laude), Smelvis University, Budapest, Hungary
- 2001-2003 Training in basic research on stem cells and brain tissue regeneration, Neurochemistry Laboratory, National Institute of Neurodegenerative Disorders and Stroke (NINDS), NIH, Bethesda, MD, USA
- 6/2007 Training in vascular neurosurgery, European Association for Neurosurgery, Lisbon, Portugal
- 06/2008 Training in oncological neurosurgery, European Association for Neurosurgery, Antwerp, Belgium
- 02/2009 Training in functional neurosurgery and head injuries, European Association for Neurosurgery, Prague, Czech Republic
- 02/2010 Spine and Peripheral Nerve Neurosurgery Training, European Association for Neurosurgery, Padua, Italy
- 2/2012 Neuropathology training, University of Texas MD Anderson Cancer Center, Houston, Texas, USA
- 6/2012 Bioinformatics training, University of Texas MD Anderson Cancer Center, Houston, Texas, USA
- 3/2013 Training in skull base surgical approaches, Medtronic Neurologic Technologies and The Midas Rex Institute, Texas, USA.
Research Areas and Articles
1. Clinical research in malignancies of the central nervous system
2. Development of new therapeutic approaches for glioblastoma (novel drug delivery systems)
A. Use of genetic engineering for the purpose of paralyzing genes involved in cancer as a tool for healing and treating malignant processes
B. Using cell cultures as "factories" to create nanoparticles loaded with biological drugs that work against cancer cells
C. Use of cellular and animal models to test targeted therapies against cancer
3. Identification of biological markers (biomarkers) for recurrence of central nervous system malignancies
4. Use of genomic and proteomic information for the purpose of developing diagnostic tools for early detection of disease recurrence in cancer patients who have achieved remission from their disease
Awards
- 2009 Journal of Neuro-Oncology award for a research paper presented at a conference in New Orleans, USA
- 2009 Award for clinical research work - Top Ten Abstract at the Neurosurgery Conference of the Congress of Neurological Surgeons New Orleans, USA
- 2010 European Neurosurgical Association Award for Neurosurgery Resident, Padua, Italy
- 2010 Israeli Neurosurgical Association Award for a resident in neurosurgery, Jerusalem
- 2011 "Ofek" award of the Sourasky Medical Center, Tel Aviv for an outstanding resident
- 2012 American Neurosurgery Association BrainLab International Fellowship Award, USA
- 2012 American Congress of Neurosurgery, Tumor Fellowship Award, USA
Additional lnfo
-
Languages
Hebrew | English
-
Private Medical Service
yes
-
Doctor's Legal Opinion
yes